CLRB Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)-0.57
Revenue Actual (USD)--
Cellectar Biosciences Inc Earnings Dates & Reports
This page offers detailed Cellectar Biosciences Inc earnings data including the latest Cellectar Biosciences Inc earnings report, the upcoming Cellectar Biosciences Inc earnings date, historical data and Cellectar Biosciences Inc earnings call news.
CLRB Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
CLRB FY2025 Earnings
EPS (YoY)-8.3577.12%
Revenue (YoY)----
Cellectar Biosciences Inc (CLRB) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -0.57/-0.48 | --/0.00 | -17.23% | -- |
| 5/14/2026 | 03/2026 | -1.33/-1.89 | --/0.00 | 29.26% | -- |
| 3/4/2026 | 12/2025 | -1.29/-2.29 | --/0.00 | 43.80% | -- |
| 11/13/2025 | 09/2025 | -1.41/-2.53 | --/0.00 | 44.40% | -- |
| 8/14/2025 | 06/2025 | -3.39/-3.90 | --/0.00 | 13.17% | -- |
| 5/13/2025 | 03/2025 | -4.30/-4.90 | --/0.00 | 12.25% | -- |
| 3/13/2025 | 12/2024 | -1.68/-10.57 | --/0.00 | 84.07% | -- |
| 11/18/2024 | 09/2024 | -11.18/-11.18 | --/0.00 | -0.08% | -- |
Cellectar Biosciences Inc Latest Earnings Call Transcripts
Cellectar Biosciences (CLRB) Q2 2026 Earnings Call: Phase III Startup and 2027 NDA Plan
Cellectar Biosciences’ Q2 2026 earnings call covered $34.0 million in cash, iopofosine Phase III startup, 2027 NDA plans and CLR 125 progress.